Peptides
JBJS Journal of Orthopaedics for Physician Assistants · 2026-07 · 14 (3) · e26.00009
DOI: 10.2106/jbjs.jopa.26.00009 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBJS Journal of Orthopaedics for Physician Assistants, 2026-07. Verfasst von Farboud Aria und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Biologically active peptides are increasingly popular on social media and in athletic communities due to claims of musculoskeletal (MSK) regenerative or healing potential. Patients are inquiring about the safety and efficacy of these synthetic drugs, and MSK practitioners may not be equipped with sufficient knowledge to guide them. Regulatory bodies have restricted their approved medical usage. The purpose of this narrative review is to summarize the literature for studies involving peptide use in potential orthopaedic applications, including tendon, ligament, bone, muscle, and wound healing. A systematic search of PubMed, Embase, and MEDLINE was conducted using keywords generated from a previous review of the most common peptides being marketed and consumed in fitness and health circles. Included studies investigated peptide administration in animal or human models for orthopaedic-related conditions. Screening, data abstraction, and quality assessment were performed independently by reviewers using the MINORS instrument. The results were narratively synthesized due to the heterogeneity in study designs and outcomes and split into animal and human data for ease of consumption. Twelve studies with human participants were identified. MK-677 was the most studied (n = 5) treatment in humans, with uniform reporting of increased circulating insulin growth factor 1 (IGF-1) levels. One MK-677 study was terminated early due to a participant death from congestive heart failure. Teriparatide, a nongrowth hormone related peptide (nGHRP) and rhBMP-2 (nGHRP) showed positive effects on fracture healing, while growth hormone related peptides (GHRPs) such as growth hormone releasing hormone (GHRH), Ghrelin, and Hexarelin yielded mixed results. BPC-157 was the most frequently studied molecule in animals. This nGHRP consistently exhibited enhanced muscle, tendon and ligament healing, and superior biomechanical performance, demonstrated through denser reticulin and collagen fibers, increased ex vivo outgrowth of tendon fibroblasts, and accelerated the induction of cell spreading of tendon fibroblasts. No studies have tested BPC-157 in human subjects. This systematic review demonstrates that GHRP and GHRP-like molecules hold potential for enhancing musculoskeletal repair and regeneration. The current body of human evidence remains sparse, and inconsistent. The safety of their use, effective route of administration and human clinical indications remain unknown. This review highlights the need for well-designed human studies that assess functional, structural, and patient-centered outcomes using standardized protocols and pharmaceutical-grade peptides. Level of Evidence: Level IV , narrative review of Level II to IV studies. See Instructions for Authors for a complete description of levels of evidence.
Zitieren
APA
Aria, F., Shah, P., Omoseni, S., Shah, A., Gagnier, J., & Wasserstein, D. (2026). Peptides. JBJS Journal of Orthopaedics for Physician Assistants, 14(3), e26.00009. https://doi.org/10.2106/jbjs.jopa.26.00009
Vancouver
Aria F, Shah P, Omoseni S, Shah A, Gagnier J, Wasserstein D. Peptides. JBJS Journal of Orthopaedics for Physician Assistants. 2026;14(3):e26.00009. doi:10.2106/jbjs.jopa.26.00009
BibTeX
@article{Aria2026,
author = {Aria, Farboud and Shah, Param and Omoseni, Sean and Shah, Ajay and Gagnier, Joel and Wasserstein, David},
title = {Peptides},
journal = {JBJS Journal of Orthopaedics for Physician Assistants},
year = {2026},
volume = {14},
number = {3},
pages = {e26.00009},
doi = {10.2106/jbjs.jopa.26.00009}
}
EUVIMED